West Nile virus vaccine candidates attenuated by dinucleotide enrichment are immunogenic and protective against lethal infection
PLOS Pathogens · 2025
DOI: 10.1371/journal.ppat.1013560 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Nguyen Phuong Khanh Le und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, United States of America. Hauptthemen laut MEDLINE: West Nile Fever, West Nile virus, West Nile Virus Vaccines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
West Nile virus (WNV) poses a global public health threat. This study demonstrates that the WNV RNA tolerates CpG and UpA dinucleotide enrichment in different genomic regions resulting in attenuation of CpG- and CpG/UpA-enriched variants. Attenuation was zinc finger antiviral protein 1 (ZAP)-dependent, and ZAP knockout (ZAP-KO) cells were used to generate high-titer stocks. Ten enriched variants, with permuted control and wild-type (WT) viruses, were screened in immunocompetent mice upon intraperitoneal injection. In contrast to lethal WNV-WT and permuted viruses, the E-MAX variant, with the RNA region encoding envelope (E) protein enriched both with CpG and UpA, caused no mortality. E-MAX was immunogenic and protective against lethal challenge. Stability of enriched dinucleotides was confirmed upon serial passaging in ZAP-WT and ZAP-KO cells, with only minor (17–21%) reversion at a single site in ZAP-WT condition. E-MAX upregulated interferon (IFN) signaling genes in human cells, suggesting that the combination of CpG/UpA-mediated attenuation, and concurrent activation of IFN responses potentially driven by CpG/UpA enrichment, may contribute to E-MAX immunogenicity. Evaluation using footpad injection in mice showed E-MAX had a promising safety and immunogenicity profile, although brain infection was occasionally detected. Then, we developed the E-MAX+ FR variant by combining CpG/UpA enrichment with two amino acid substitutions in functional domains of the E protein. This strategy eliminated neuroinvasion while maintaining immunogenicity and protection. Altogether, CpG/UpA dinucleotide enrichment in the genomic E region in combination with amino acid substitutions in the E protein yields a promising platform for vaccine development against WNV and potentially other flaviviruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, United States of America.
- School of Public Health, Vaccinology and Immunotherapeutics Program, University of Saskatchewan, Saskatoon, Canada.
- Dioscuri Centre for RNA-Protein Interactions in Human Health and Disease, International Institute of Molecular and Cell Biology, Warsaw, Poland.
- Veterinary Microbiology Department, Wester College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Canada.
- Center for RNA Biology, The Ohio State University, Columbus, Ohio, United States of America.
- Infectious Disease Institute, The Ohio State University, Columbus, Ohio, United States of America.
ORCID-Profile: Uladzimir Karniychuk
Zitieren
APA
Le, N. P. K., Singh, P. P., Trus, I., & Karniychuk, U. (2025). West Nile virus vaccine candidates attenuated by dinucleotide enrichment are immunogenic and protective against lethal infection. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013560
Vancouver
Le NPK, Singh PP, Trus I, Karniychuk U. West Nile virus vaccine candidates attenuated by dinucleotide enrichment are immunogenic and protective against lethal infection. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013560
BibTeX
@article{Le2025,
author = {Le, Nguyen Phuong Khanh and Singh, Prince Pal and Trus, Ivan and Karniychuk, Uladzimir},
title = {West Nile virus vaccine candidates attenuated by dinucleotide enrichment are immunogenic and protective against lethal infection},
journal = {PLOS Pathogens},
year = {2025},
doi = {10.1371/journal.ppat.1013560}
}
EUVIMED